Use of prostate-specific membrane antigen positron-emission tomography/CT in response assessment following upfront chemohormonal therapy in metastatic prostate cancer.
Angelyn AntonOlfat Kamel HasanZita BallokPatrick BowdenAnthony J CostelloLaurence HarewoodNiall M CorcoranPhil DundeeJustin S PetersNathan L LawrentschukAndrew TroyDavid WebbYee ChanAndrew SeeShankar SivaDeclan G MurphyMichael S HofmanBen TranPublished in: BJU international (2020)